Acacia Pharma Group PLC (EUR)
ACPH
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range2.78 | 2.87
52-Wk Range- | -
Last Close2.84
Mkt Cap (m)192.37
Dividend yield-
ISINGB00BYWF9Y76
Volume114,846.00
Exchange VenueBRU

Company Profile

Acacia Pharma Group PLC is a pharmaceutical company, focused on the development and commercialization of hospital products for US and international markets to treat and prevent nausea and vomiting suffered by surgical and cancer patients.

Key Information
Price/Earning-
Price/Book50.00
Price/Sales-
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-158.24
Debt/Equity2.34

Documents

Prospectus
en 02/03/2018
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.acaciapharma.com

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)------
Operating Income (m)--18.47-17.82-4.07-19.08-22.39
Net Income (m)--19.07-16.65-8.34-19.69-22.84
Basic EPS--7.18-6.27-0.16-0.44-0.43
Avg. Diluted Shares Outstanding (m)-2.662.6652.9244.0953.68
Balance Sheet
EUR201420152016201720182019
Current Assets (m)-11.8012.604.8338.5118.30
Non Current Assets (m)-0.000.000.000.000.37
Total Assets (m)-11.8012.604.8338.5118.67
Current Liabilities (m)-15.9420.9528.865.159.62
Total Liabilities (m)------
Total Equity (m)--4.14-14.48-24.0324.524.35
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)--14.42-12.59-5.07-14.78-19.83
Capital Expenditure (m)------
Figures are quoted in EUR unless stated otherwise
-
No change
2.84
Last Price